Acadia Pharmaceuticals Inc
ACAD· Nasdaq
ACADAcadia Pharmaceuticals Inc
Released Nov 6, 2013, after the close
10-Q filed Nov 6, 2013, 37 days after period end · 0001193125-13-430089
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2013 | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|---|
| Revenue | $240.00K | $3.48M | $584.00K | $2.30M |
| Net Income | -$10.70M | -$2.40M | -$5.08M | -$4.23M |
| EPS Diluted | -$0.12 |
Acadia Pharmaceuticals Inc · CIK 1070494 · Engraved from SEC EDGAR
| -$0.04 |
| -$0.10 |
| -$0.11 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
